Latest Trials

EudraCT Number: 2004-000930-35 Sponsor Protocol Number: MHE100901 Start Date: 2005-05-26
Sponsor Name: GLAXO SMITHKLINE
Full Title: An open-label extension study to study 100185, to evaluate long-term safety, efficacy and optimal dosing frequency of 750mg intravenous mepolizumab in subjects with hypereosinophilic syndrome.
Medical condition: HES
Disease: Version SOC Term Classification Code Term Level
14.1 10005329 - Blood and lymphatic system disorders 10048643 Hypereosinophilic syndrome PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed) BE (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe